Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-15-001814
Filing Date
2015-07-16
Accepted
2015-07-15 20:27:04
Documents
9
Period of Report
2015-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s101424_10q.htm 10-Q 393709
2 EXHIBIT 33.1 s101424_ex31-1.htm EX-31.1 10365
3 EXHIBIT 32.1 s101424_ex32-1.htm EX-32.1 4520
  Complete submission text file 0001615774-15-001814.txt   3036536

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mcet-20150531.xml EX-101.INS 493766
5 XBRL SCHEMA FILE mcet-20150531.xsd EX-101.SCH 43394
6 XBRL CALCULATION FILE mcet-20150531_cal.xml EX-101.CAL 38837
7 XBRL DEFINITION FILE mcet-20150531_def.xml EX-101.DEF 171532
8 XBRL LABEL FILE mcet-20150531_lab.xml EX-101.LAB 294927
9 XBRL PRESENTATION FILE mcet-20150531_pre.xml EX-101.PRE 228859
Mailing Address 68 CUMBERLAND STREET, SUITE 301 WOONSOCKET RI 02865
Business Address 68 CUMBERLAND STREET, SUITE 301 WOONSOCKET RI 02865 (401)762-0045
MultiCell Technologies, Inc. (Filer) CIK: 0000811779 (see all company filings)

EIN.: 521412493 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-10221 | Film No.: 15990278
SIC: 2834 Pharmaceutical Preparations